Example collocations logo

Vaccines in sentence

693 examples of Vaccines in a sentence

HPV vaccines can prevent 70% of these cases by targeting the two most common types of the virus, but only if girls have not yet been exposed to the virus, which means vaccinating them before they become sexually active.
And now, with help from my organization, the GAVI Alliance, a public-private partnership created to improve access to new vaccines for the world’s poorest children, other low-income countries are following Rwanda’s lead.
As of this year, Ghana, Kenya, Laos, Madagascar, Malawi, Mozambique, Niger, Sierra Leone, Tanzania, and Zimbabwe have all taken steps to introduce HPV vaccines, with more countries expected to follow.
Likewise, empathy with a handful of children who are, or are believed to be, harmed by vaccines largely drives popular resistance to vaccinating children against dangerous diseases.
Though several experimental treatments and at least two candidate vaccines had been in development when Ebola emerged unexpectedly early this year, progress had stalled well before any were deemed ready to be tested in humans.
After all, clinical research to assess the safety and effectiveness of new drugs and vaccines can happen only during an epidemic.
In order to accelerate progress, governance of the clinical trials must be transparent, and all knowledge about the disease, including developments regarding potential treatments and vaccines, must be shared openly – imperatives that will require strong public-health leadership in both the Mano River countries and the developed world.
Running clinical trials under the auspices of affected countries’ health ministries and the WHO – with full transparency in terms of processes and outcomes – would enable the relevant authorities to make timely and informed decisions regarding which treatments and vaccines to investigate further and when to deploy them.
In fact, some of humanity’s greatest innovations – from vaccines to brain surgery – were pioneered by Africans.
And net returns exceed costs for all vaccines.
And there have been extraordinary advances in the number and kinds of vaccines that are available.
Beyond inadequately financed health systems, which remain weak and inefficient, especially in rural areas, African countries face challenges in affording new, more expensive vaccines.
New vaccines should be enabling us to save more lives.
Another study showed that in 2001, the total cost of the original set of six World Health Organization-recommended vaccines was less than one dollar.
In 2014, the number of WHO-recommended vaccines had risen to 11 – and the cost had reached about $21 for boys and $35 for girls.
That same study found that, in many low- and middle-income countries, immunization budgets are currently insufficient to sustain vaccination programs, much less incorporate the new costlier vaccines.
For some countries, the situation is about to get worse, as Gavi, the international group which has helped to finance the dramatic global expansion of new vaccines, phases out support for countries deemed to have “graduated” from assistance.
Without eligibility for the lower prices obtained by Gavi, many of these countries may not be able to afford newer vaccines.
In order to cope with this challenge, African political leaders have committed to invest in the continent’s capacity to develop and produce its own vaccines.
In the short to medium term, African countries would do well to look into the power of collective bargaining to strike better deals for needed vaccines.
That question will soon need to be answered, because both the pharmaceutical giant GlaxoSmithKline (in conjunction with the US National Institute of Allergy and Infectious Diseases) and the Public Health Agency of Canada have candidate vaccines in development.
The Full Value of Childhood VaccinesGENEVA – If you want to know the value of vaccines, just spend some time in a clinic in Africa.
The faces of the mothers and fathers say it all: vaccines prevent illness and save lives.
What all of this means is that by measuring the effectiveness of vaccines merely in terms of “lives saved,” we could be seriously underestimating the full extent of the benefits that they offer.
As things stand, in terms of the cost effectiveness of health interventions, vaccines are already considered one of public policy’s “best buys.”
But now, as more evidence is gathered, it looks likely that even this may not do justice to the full value of vaccines.
But, with current estimates indicating that, by 2030, only half the world’s children will be fully immunized with the 11 vaccines recommended globally by the World Health Organization, we clearly still have some way to go.
At the same time, we now know that the value of vaccines extends far beyond the number of lives saved.
Investment in vaccines is not about short-term savings, either in terms of lives or economic costs; it is about providing children with lifetime protection and the ability to realize their full potential.
Scientific and technological advances – from new vaccines and hardier crops to much cheaper smartphones and tablets – are among the greatest drivers of poverty reduction.
BackNext